kezar life sciences stock news
Das Papier gehört zum Segment Biotechnologie. Kezar Life Sciences zählt zum Segment Biotechnologie.
Is This Flaming Hot Biotech Stock A Buy The Motley Fool
The holding were 3228200 shares as of 2021-12-31.
. Avidity Partners Management LP added to a holding in Kezar Life Sciences Inc by 114162. The purchase prices were between 744 and 1672 with an estimated average price of 1143. An der Heimatbörse NASDAQ GS notiert Kezar Life Sciences per 21012022 1326 Uhr bei 1232 USD.
The stock is now traded at around 15230000. The impact to a portfolio due to this purchase was 105. Der Kezar Life Sciences-Kurs wird am 28012022 1219 Uhr an der Heimatbörse NASDAQ GS mit 1235 USD festgestellt.
We Re Not Very Worried About Kezar Life Sciences Nasdaq Kzr Cash Burn Rate Simply Wall St News
Kezar Life Sciences Kzr Stock Why The Price Surged Today
Kezar Life Sciences Targeting The Immunoproteasome To Treat Autoimmunity Nasdaq Kzr Seeking Alpha
Kezar Life Sciences Inc Shares Near 52 Week High Market Mover Nasdaq
Why Kezar Life Sciences Stock Is Soaring Today Nasdaq
Oxford Finance Provides 50 Million Credit Facility To Kezar Life Sciences Inc
Kezar Life Sciences Inc Kzr Stock Price News Info The Motley Fool
Where Does Kezar Life Sciences Inc Kzr Stock Fall In The Biotechnology Field After It Is Up 3 04 This Week
Kezar Life Sciences Prepares For U S Ipo Nasdaq Kzr Seeking Alpha
Kzr Stock Price And Chart Nasdaq Kzr Tradingview
Where Does Kezar Life Sciences Inc Kzr Stock Fall In The Biotechnology Field After It Is Up 3 04 This Week
Kezar Life Sciences Inc Kzr Stock What Does The Chart Say Wednesday
Kzr Institutional Ownership Kezar Life Sciences Inc Stock
Kzr Stock Price And Chart Nasdaq Kzr Tradingview
Kezar Life Sciences Targeting The Immunoproteasome To Treat Autoimmunity Nasdaq Kzr Seeking Alpha
Kzr Short Interest Kezar Life Sciences Inc Stock Short Squeeze Short Sale Volume Borrow Rates Fails To Deliver
Kezar Life Sciences Inc Share Price Usd0 001
Kezar Life Sciences Nasdaq Kzr Cut To Hold At Zacks Investment Research Marketbeat